slide_ID,MC_score,class
H0069931 OET 1-1 HPS - 2023-10-23 17.34.44,1.0,Diffuse paediatric-type high grade glioma
18R00721-H0066922 MOU 2E HPS - 2023-10-24 18.00.05,0.999999348,CNS embryonal tumour with BRD4:LEUTX fusion
21H02090 BOU 2-3 HPS - 2023-10-27 16.02.52,0.999998643,Diffuse paediatric-type high grade glioma
19H01653 DEG HPS - 2023-10-12 15.03.06,0.999996889,"Adult-type diffuse high grade glioma, IDH-wildtype"
19H01535 ALO 1-5 HPS - 2023-10-25 15.02.19,0.999991735,Diffuse leptomeningeal glioneuronal tumour
14H00342 FAH 1-1 HPS - 2023-10-25 17.46.07,0.999973681,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
14H00342 FAH 1-1 HPS - 2023-10-27 14.51.19,0.999973681,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
22H00440 CAR 1-1 HPS - 2023-10-31 12.26.25,0.999971252,CNS Embryonal tumour with PLAG-family amplification
19H01760 RIA 1-1 HPS - 2023-10-12 13.53.47,0.999965986,Atypical teratoid rhabdoid tumour
19R00314 MON HPS - 2023-10-12 13.46.01,0.999962477,"Astroblastoma, MN1-altered, MN1:BEND2-fused"
21H01170 HAM 1-2 HPS - 2023-10-25 14.50.24,0.999961261,"Diffuse midline glioma, H3 K27-altered"
18H00426 GON 3-1 HPS - 2023-10-25 11.47.18,0.999952259,"Diffuse midline glioma, H3 K27-altered"
20H01584 4-6 HPS - 2023-10-25 17.38.38,0.999945133,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
17H01825 GNY 1-2 HPS - 2023-10-25 11.41.35,0.999911906,"Diffuse midline glioma, H3 K27-altered"
H0063696 TEG 1-5 HPS - 2023-10-12 13.24.28,0.999904097,Dysembryoplastic neuroepithelial tumour
19H01774 REB 1-2 HPS - 2023-10-06 17.36.42,0.999886235,Diffuse paediatric-type high grade glioma
H0063676 CRU 1-1 HPS - 2023-10-24 17.33.16,0.999878028,CNS tumour with BCOR internal tandem duplication
22H00438 COL 1-1 HPS - 2023-10-06 17.04.13,0.999871564,"glioblastoma, IDH-wildtype"
22H00438 COL 2-1 HPS - 2023-10-09 11.56.00,0.999871564,"glioblastoma, IDH-wildtype"
20H01043 BIG 02 HPS - 2023-10-30 16.04.06,0.999867672,"CNS neuroblastoma, FOXR2-altered"
21H01591 YIL 6B1 HPS - 2023-10-25 17.33.20,0.999865822,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
18H00846 SAN 2-2 HPS - 2023-10-25 11.44.48,0.999861715,"Diffuse midline glioma, H3 K27-altered"
21R00038 2A HPS - 2023-10-30 17.21.55,0.999842075,Atypical teratoid rhabdoid tumour
21H01888 GON 2-1 HPS - 2023-10-09 14.29.12,0.999838988,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
21H00727 MAL 1-1 HPS - 2023-10-09 11.50.22,0.999837718,"glioblastoma, IDH-wildtype"
H0063639 CAN 2G HPS - 2023-10-24 18.19.52,0.999816661,"Astroblastoma, MN1-altered, MN1:BEND2-fused"
23H01054 THI 1-7 HPS - 2023-10-06 17.37.37,0.999806141,Ganglioglioma
19R00098 GOR 2E HPS - 2023-10-30 16.56.15,0.999792803,"CNS neuroblastoma, FOXR2-altered"
23R00001 SOR HPS - 2023-10-25 11.49.08,0.999786762,"Diffuse midline glioma, H3 K27-altered"
20H01028 MOU HES - 2020-08-13 13.05.56,0.99977571,Diffuse paediatric-type high grade glioma
H0065390 TRI 1-2 HPS - 2023-10-12 13.30.45,0.999762854,Dysembryoplastic neuroepithelial tumour
22H01525 GAR 1-3 HPS - 2023-10-12 15.36.20,0.999722936,Ganglioglioma
20H01316 BRO HPS - 2023-10-30 15.08.34,0.999706684,CNS tumour with EP300:BCOR(L1) fusion
21H01739 AHM 1B HPS - 2023-10-31 12.35.38,0.999652458,choroid plexus papilloma
H0062307 CIT 2B HPS - 2023-10-24 18.18.56,0.999629979,Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters
18H00252 DEB 1-1 HPS - 2023-10-10 11.55.28,0.999585812,"Angiocentric glioma, MYB/MYBL1-altered"
21H01453 OUA 3-3 HPS - 2023-10-30 15.16.08,0.999570706,CNS tumour with EP300:BCOR(L1) fusion
22H00051 CER 1-2 HPS - 2023-10-31 12.22.55,0.999468932,Atypical teratoid rhabdoid tumour
18H00571 LE G 2-2 HPS - 2023-10-25 14.55.22,0.999382867,"Diffuse midline glioma, H3 K27-altered"
17R00858-H0072678 BAO 2-1 HPS - 2023-10-26 12.30.35,0.999067438,Diffuse paediatric-type high grade glioma
18R00826 FLA B HPS - 2023-10-31 11.05.32,0.999059505,"CNS neuroblastoma, FOXR2-altered"
18B00098 PRU HPS - 2023-10-12 15.09.00,0.998990473,"Astroblastoma, MN1-altered, MN1:BEND2-fused"
17R00885-15H00973 KHA 2-9 HPS - 2023-10-30 16.49.23,0.998897795,CNS tumour with BCOR internal tandem duplication
18H01963 VIM 1-2 HPS - 2023-10-26 12.10.27,0.998565293,Diffuse paediatric-type high grade glioma
20H00467 YAK 1-1 HPS - 2023-10-25 14.49.27,0.998382662,"Diffuse midline glioma, H3 K27-altered"
19R00312 FER HPS - 2023-10-30 17.40.06,0.998244838,"Astroblastoma, MN1-altered, MN1:BEND2-fused"
18H00267 HAS 1-3 HPS - 2023-10-12 14.58.56,0.998084,posterior fossa ependymoma group B
H0070447 ISP 1-1 HPS - 2023-10-23 18.05.55,0.99790557,Diffuse paediatric-type high grade glioma
19H00750 YAN 1-1 HPS - 2023-10-23 13.09.24,0.99753382,"supratentorial ependymoma, ZFTA fusion-positive"
23H01026 LEC 1-1 HPS - 2023-10-06 16.39.29,0.996852899,pilocytic astrocytoma
20H00879 ACH HPS - 2023-10-09 12.34.02,0.996366071,CNS Embryonal tumour with PLAG-family amplification
19H00685 KAM 1-1 HPS - 2023-10-25 14.48.45,0.996285545,"Diffuse midline glioma, H3 K27-altered"
H0064204 SAI 1 HPS - 2023-10-23 17.46.14,0.996025357,Diffuse paediatric-type high grade glioma
16H00626 BEA 1-1 HPS - 2023-10-25 14.46.04,0.995759076,Diffuse leptomeningeal glioneuronal tumour
H0074779 SOU 1-1 HE_2015-04-16 10.33.11,0.995430737,Ganglioglioma
18H00930 ZER 1-1 HPS - 2020-12-18 12.58.55,0.994766609,"diffuse glioma, MYB- or MYBL1-altered"
16H00034 ELW 2-1 HPS - 2021-01-29 15.30.54,0.994461457,"Control tissue, blood"
16H00034 4-1 HPS - 2023-10-10 12.58.47,0.994461457,"Control tissue, blood"
21H00785 MBO 1-3 HPS - 2023-10-31 12.42.32,0.994275777,Atypical teratoid rhabdoid tumour
H0065434 LEC 1-2 HPS - 2023-10-24 17.37.53,0.994084109,Atypical teratoid rhabdoid tumour
23H00486 1BIS3 HPS - 2023-10-12 15.17.38,0.994008166,Diffuse paediatric-type high grade glioma
19H00161 DMI HPS - 2023-10-10 12.07.45,0.99382975,Inflammatory microenvironment
21H01596 GAN 3E HPS - 2023-10-25 17.26.00,0.993147726,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
20H01263 LOP 1-4 HPS - 2023-10-09 14.14.43,0.992887681,"Diffuse midline glioma, H3 K27-altered"
22H01655 SAM 5-5 HPS - 2023-10-30 11.36.42,0.992031205,CIC-rearranged sarcoma
21H00154 GAH 1B HPS - 2023-10-30 16.11.43,0.989009907,"CNS neuroblastoma, FOXR2-altered"
17H00011 AVA 3-1 HPS - 2023-10-11 15.55.30,0.98742833,High-grade astrocytoma with piloid features
16R00442 14H00852 3-1 ARC HPS - 2023-10-10 12.30.50,0.98742712,Ganglioglioma
16R00442 14H00852 ARC HPS - 2023-10-10 12.30.50,0.98742712,Ganglioglioma
H0073009 SOU 2-3 HPS - 2023-10-11 17.27.44,0.987367926,Ganglioglioma
17H01081 CHE 1-2 HPS - 2023-10-26 16.49.39,0.986882838,"Control tissue, reactive tumour microenvironment"
17H01081 CHE 1-2 HPS - 2023-10-30 15.19.49,0.986882838,"Control tissue, reactive tumour microenvironment"
14R00275-H0067369 2-4 NAD - 2023-10-27 15.44.11,0.986648683,Diffuse paediatric-type high grade glioma
23H00328 JAQ 1-2 HPS - 2023-10-12 15.38.54,0.986613354,High-grade astrocytoma with piloid features
20H00127 ANT A2 HPS - 2023-10-23 13.18.58,0.98653398,Diffuse leptomeningeal glioneuronal tumour
22H01284 ALE 1-4 HPS - 2023-10-26 12.14.44,0.98642577,Diffuse paediatric-type high grade glioma
17H01859 RAG 3-3 HPS - 2023-10-23 13.21.06,0.98549565,"Diffuse midline glioma, H3 K27-altered"
17H01859 RAG 3-3 HPS - 2023-10-26 17.40.28,0.98549565,"Diffuse midline glioma, H3 K27-altered"
19H01775 BOU 2-1 HPS - 2023-10-09 16.59.50,0.982984666,Dysembryoplastic neuroepithelial tumour
20H00591 BAR HPS - 2023-10-09 16.52.26,0.982950152,CNS tumour with BCOR internal tandem duplication
H0074254 COS 2-2 HPS - 2023-10-30 17.49.03,0.981354013,Dysembryoplastic neuroepithelial tumour
20H01364 GOU 2-2 HPS - 2023-10-31 12.44.32,0.981314668,Atypical teratoid rhabdoid tumour
H0074297 LAT 1-1 HPS - 2023-10-31 10.49.32,0.981238552,Dysembryoplastic neuroepithelial tumour
15H01130 HUR 1-1 HPS - 2023-10-10 18.10.33,0.97962885,Dysembryoplastic neuroepithelial tumour
H0073040 QUA 1-7 HPS - 2023-10-24 18.02.41,0.978720927,"Astroblastoma, MN1-altered, MN1:BEND2-fused"
20H00919 BOT 2-1 HPS - 2023-10-12 14.53.10,0.978069892,pilocytic astrocytoma
19H01270 BIT HPS - 2023-10-12 15.29.37,0.977265126,Dysembryoplastic neuroepithelial tumour
14R00025-H0063563 GRE 3-2 HPS - 2023-10-26 16.15.18,0.97575888,Diffuse paediatric-type high grade glioma
R0000324 DES 6B HPS - 2023-10-12 15.42.37,0.97413281,"Medulloblastoma, WNT activated"
18H01971 CAS HPS - 2023-10-23 13.12.11,0.974117735,Diffuse paediatric-type high grade glioma
16H00304 FER 1-3 HPS - 2023-10-09 11.27.43,0.970089229,Dysembryoplastic neuroepithelial tumour
19H00492 CHA 4-1 HPS - 2023-10-30 15.01.23,0.969911988,CNS tumour with EP300:BCOR(L1) fusion
20H00273 GAR 3-4 HPS - 2023-10-11 12.46.05,0.969707312,Rhabdomyosarcoma
16H01222 LEC 3-1 HPS - 2023-10-10 18.03.14,0.969293717,Diffuse leptomeningeal glioneuronal tumour
22H01865 CAB 1-1 HPS - 2023-10-09 16.44.47,0.96784746,"glioblastoma, IDH-wildtype"
22H00613 MAT 1-1 HPS - 2023-10-27 15.37.50,0.965410134,"Astrocytoma, IDH-mutant"
18H01253 TAL 1-1 HPS - 2023-10-09 17.16.01,0.964181224,Diffuse paediatric-type high grade glioma
17H00758 KHU 1-1 HPS - 2023-10-09 15.28.22,0.963777327,Dysembryoplastic neuroepithelial tumour
23H00148 LEL 2-3 HPS - 2023-10-23 13.02.20,0.960058475,Pleomorphic xanthoastrocytoma
H0048309 LAM 1B HPS - 2023-10-11 17.44.50,0.958103752,"Diffuse midline glioma, H3 K27-altered"
23H00245 JAU 2-2 HPS - 2023-10-10 12.36.23,0.955656888,Dysembryoplastic neuroepithelial tumour
21H01361 AMM 2-2 HPS - 2023-10-27 15.55.52,0.954908847,"diffuse glioma, MYB- or MYBL1-altered"
16H01093 BOI 3F HPS - 2023-10-26 12.21.17,0.947194172,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
H0069816 LEB 1-1 HPS - 2023-10-11 17.14.00,0.939837654,Dysembryoplastic neuroepithelial tumour
21H00975 LAR HPS - 2023-10-10 12.43.42,0.939082785,"diffuse glioma, MYB- or MYBL1-altered"
15H01827 MOM 1-2 HPS - 2023-10-06 17.51.33,0.936181383,Dysembryoplastic neuroepithelial tumour
20H01916 SEY 2-5 HPS - 2023-10-11 15.49.20,0.934187739,High-grade astrocytoma with piloid features
23H00360 LEM 1-1 HPS - 2023-10-10 12.05.15,0.931532416,High-grade astrocytoma with piloid features
19R00370 BAH 2-5 HPS - 2023-10-06 16.44.52,0.931054869,"meningioma, intermediate"
22H01909 POI 1-1 HPS - 2023-10-09 12.42.00,0.931037088,"CNS neuroblastoma, FOXR2-altered"
20H00058 BAZ 1-2 HPS - 2023-10-06 17.59.23,0.92540074,Diffuse leptomeningeal glioneuronal tumour
19H01620 ELH HPS - 2023-10-11 16.00.47,0.923865366,medulloblastoma Group 3
15H01146 CAR 2G HPS - 2023-10-09 17.18.53,0.923784018,Dysembryoplastic neuroepithelial tumour
21H01802 DRE 2-1 HPS - 2023-10-10 18.06.48,0.921628194,Dysembryoplastic neuroepithelial tumour
18H00905 HAD 01 HPS - 2023-10-30 16.20.25,0.916705263,CNS tumour with BCOR internal tandem duplication
20H01676 TAR 1-1 HPS - 2023-10-30 15.24.55,0.915525844,"Control tissue, reactive tumour microenvironment"
19B00323 H0072705 TRI HPS - 2023-10-11 16.19.12,0.907026187,"supratentorial ependymoma, ZFTA fusion-positive"
20H01350 PEN HPS - 2023-10-09 13.02.05,0.903365774,Dysembryoplastic neuroepithelial tumour
20H00973 MAS 1-2 HPS - 2023-10-10 18.16.49,0.89631277,posterior fossa ependymoma group B
21H01791 GUE HPS - 2023-10-10 12.14.07,0.896085721,choroid plexus papilloma
20H00788 CAB 2-1 HPS - 2023-10-09 15.36.16,0.89190863,"Control tissue, reactive tumour microenvironment"
19H01372 BAD 3-1 HPS - 2023-10-11 12.38.56,0.880255918,"supratentorial ependymoma, ZFTA fusion-positive"
19H01372BAD 3-1 HPS - 2023-10-11 12.38.56,0.880255918,"supratentorial ependymoma, ZFTA fusion-positive"
19R00137 15H01212 DEM HPS - 2023-10-09 13.04.11,0.879844333,pilocytic astrocytoma
23H00417 PRA 2-1 HPS - 2023-10-09 11.08.22,0.875285154,pilocytic astrocytoma
23H00069 FAI 1-2 HPS - 2023-10-10 12.41.01,0.873294405,"Control tissue, reactive tumour microenvironment"
21H01920 BOU 1-1 HPS - 2023-10-09 15.34.03,0.865372068,choroid plexus papilloma
22H00133 CUE A2 HPS - 2023-10-09 15.32.57,0.853520055,"Adult-type diffuse high grade glioma, IDH-wildtype"
20H00525 EL H HPS - 2023-10-09 12.03.17,0.853334884,normal pineal gland and pineocytoma
19R00200 JEN HPS - 2023-10-25 11.54.16,0.843104087,Diffuse paediatric-type high grade glioma
H0062369 BEV 1B HPS - 2023-10-24 17.35.31,0.842718385,"Astroblastoma, MN1-altered, MN1:BEND2-fused"
H0070293 MEN 3-1 HPS - 2023-10-11 17.39.32,0.831740502,"supratentorial ependymoma, ZFTA fusion-positive"
19H01132 TIM 1-4 HPS - 2023-10-11 12.52.52,0.82268085,"Control tissue, reactive tumour microenvironment"
20H00883 MAS 1-7 HPS - 2023-10-10 17.56.33,0.81210632,Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
14R00279-H0068550 JOU 1-3 HPS - 2023-10-26 16.06.29,0.795117748,Diffuse paediatric-type high grade glioma
14R00044-H0069414 RIG 1-1 HPS - 2023-10-26 16.09.10,0.778565753,Diffuse paediatric-type high grade glioma
23H00339 TOU 1-1 HPS - 2023-10-27 16.04.20,0.765274705,Diffuse paediatric-type high grade glioma
18R00346 PER 1-1 HPS - 2023-10-11 17.04.31,0.757623969,pilocytic astrocytoma
18R00346 PER HPS - 2023-10-11 17.04.31,0.757623969,pilocytic astrocytoma
21H01509 FAB HPS - 2023-10-09 14.34.36,0.741938988,"glioblastoma, IDH-wildtype"
16H01514 KOU HPS - 2023-10-10 18.05.58,0.721992179,"Diffuse midline glioma, H3 K27-altered"
20H00699 JEH HPS - 2023-10-09 15.34.29,0.714240029,"Control tissue, reactive tumour microenvironment"
22H01060 CRE 1-1 HPS - 2023-10-09 14.22.48,0.707997356,"glioblastoma, IDH-wildtype"
15H01141 PAS 1A HPS - 2023-10-09 11.23.15,0.686537316,pilocytic astrocytoma
18R00383 H0073991 AMA HPS - 2023-10-09 13.16.31,0.672809658,CNS tumour with BCOR internal tandem duplication
19H00282 DA 2-2 HPS - 2023-10-23 13.28.29,0.629160063,Diffuse paediatric-type high grade glioma
19H00570 BEN A3 HPS - 2023-10-09 17.08.53,0.626754096,Extraventricular neurocytoma
19R00126 H0069119 BER 3-2 HPS - 2023-10-11 17.46.22,0.609555526,pilocytic astrocytoma
H0068971 CIR 1-2 HPS - 2023-10-11 17.06.12,0.575261907,control tissue
19H02168 DES HPS - 2023-10-09 11.45.01,0.567607497,CNS tumour with BCOR internal tandem duplication
H0063468 KOD 2H HPS - 2023-10-24 18.08.36,0.56599001,"Astroblastoma, MN1-altered, MN1:BEND2-fused"
20H00369 AND 1-1 HPS - 2022-11-08 11.44.59,0.551041391,Ganglioglioma
16R00163 MOR HPS - 2023-10-11 13.03.28,0.547548976,Diffuse paediatric-type high grade glioma
17H00231 KAM 2-3 HES - 2023-09-28 14.29.15,0.540859433,"glioblastoma, IDH-wildtype"
18R00345 H0074250 LEV HPS - 2023-10-09 14.49.07,0.525192432,pilocytic astrocytoma
18R00345 H0074250 LEV 1-1 HPS - 2023-10-09 14.49.07,0.525192432,pilocytic astrocytoma
20H00200 LAP 2-1 HPS - 2023-10-09 11.12.52,0.51969993,Dysembryoplastic neuroepithelial tumour
20H00005 AND 1-2 HPS - 2023-10-09 11.48.55,0.488910331,Diffuse paediatric-type high grade glioma
18H01091 HOL 08 HPS - 2021-02-01 11.58.46,0.448948779,Diffuse paediatric-type high grade glioma
17R00089 CHA HPS - 2023-10-09 12.12.50,0.440739706,posterior fossa ependymoma group B
22H01482 MOI 1-1 HPS - 2023-10-09 14.42.56,0.412454517,"medulloblastoma, SHH-activated"
22H02030 GUL 3-4 HPS - 2023-10-10 12.50.45,0.383347502,Diffuse paediatric-type high grade glioma
20H00867 GOS HPS - 2023-10-09 11.18.50,0.360044957,"medulloblastoma, SHH-activated"
H0070706 KAT 1-1 HPS - 2023-10-11 17.38.48,0.200177764,pilocytic astrocytoma
